ZYMEWORKS INC.
56Patents
56Active
56Granted
55Portfolio score
Filing activity: May 26, 2006 → Oct 7, 2019 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9562109B2 | Stable heterodimeric antibody design with mutations in the Fc domain | Chemistry; Metallurgy | 63 | Active |
| US9574010B2 | Stable heterodimeric antibody design with mutations in the Fc domain | Chemistry; Metallurgy | 37 | Active |
| US9499634B2 | Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells | Chemistry; Metallurgy | 36 | Active |
| US9522876B2 | Cytotoxic and anti-mitotic compounds, and methods of using the same | Emerging Cross-Sectional Technologies | 18 | Active |
| US10000576B1 | Bispecific antigen-binding constructs targeting HER2 | Chemistry; Metallurgy | 18 | Active |
| US9388231B2 | Multivalent heteromultimer scaffold design and constructs | Chemistry; Metallurgy | 15 | Active |
| US9499605B2 | Multivalent heteromultimer scaffold design and constructs | Chemistry; Metallurgy | 15 | Active |
| US9914785B2 | Engineered immunoglobulin heavy chain-light chain pairs and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US9879086B2 | Cytotoxic and anti-mitotic compounds, and methods of using the same | Electricity | 11 | Active |
| US10077298B2 | Engineered immunoglobulin heavy chain-light chain pairs and uses thereof | Chemistry; Metallurgy | 10 | Active |
| US7769573B2 | System and method for modeling interactions | Physics | 9 | Active |
| US10255409B2 | Systems and methods for in silico evaluation of polymers | Physics | 8 | Active |
| US9732155B2 | Crystal structures of heterodimeric Fc domains | Chemistry; Metallurgy | 8 | Active |
| US9988460B2 | Crystal structures of heterodimeric Fc domains | Chemistry; Metallurgy | 8 | Active |
| US9771573B2 | Methods of quantitating heavy and light chain polypeptide pairs | Chemistry; Metallurgy | 7 | Active |
| US9296815B2 | Antibodies with enhanced or suppressed effector function | Chemistry; Metallurgy | 5 | Active |
| US11161915B2 | Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US10947319B2 | Bispecific antigen-binding constructs targeting HER2 | Chemistry; Metallurgy | 4 | Active |
| US11078296B2 | Engineered immunoglobulin heavy chain-light chain pairs and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US11286293B2 | Engineered immunoglobulin heavy chain-light chain pairs and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US11000598B2 | Anti-HER2 biparatopic antibody-drug conjugates and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10457742B2 | Stable heterodimeric antibody design with mutations in the Fc domain | Chemistry; Metallurgy | 3 | Active |
| US10201614B2 | Cytotoxic and anti-mitotic compounds, and methods of using the same | Emerging Cross-Sectional Technologies | 3 | Active |
| US11306156B2 | Modified antigen binding polypeptide constructs and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US10414822B2 | Cytotoxic and anti-mitotic compounds, and methods of using the same | Electricity | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.